Idex Corporation (IEX)

$198.71

-5.19

(-2.55%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $198.39
    $203.29
    $198.71
    downward going graph

    0.16%

    Downside

    Day's Volatility :2.41%

    Upside

    2.25%

    downward going graph
  • $182.02
    $244.77
    $198.71
    downward going graph

    8.4%

    Downside

    52 Weeks Volatility :25.64%

    Upside

    18.82%

    downward going graph

Returns

PeriodIdex CorporationSector (Industrials)S&P500
3 Months
-9.23%
3.1%
9.5%
6 Months
-0.87%
11.9%
14.1%
1 Year
-5.1%
14.7%
22.0%
3 Years
-9.83%
21.5%
25.9%

Highlights

Market Capitalization
15.5B
Book Value
$47.68
Dividend Share
2.61
Dividend Yield
1.34%
Earnings Per Share (EPS)
7.61
PE Ratio
26.97
PEG Ratio
2.31
Wall Street Target Price
239.26
Profit Margin
17.89%
Operating Margin TTM
20.71%
Return On Assets TTM
7.86%
Return On Equity TTM
16.86%
Revenue TTM
3.2B
Revenue Per Share TTM
42.7
Quarterly Revenue Growth YOY
-5.3%
Gross Profit TTM
1.4B
EBITDA
882.4M
Diluted Eps TTM
7.61
Quarterly Earnings Growth YOY
-0.13
EPS Estimate Current Year
8.29
EPS Estimate Next Year
9.06
EPS Estimate Current Quarter
1.76
EPS Estimate Next Quarter
2.12

Analyst Recommendation

Buy
    57%Buy
    42%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Idex Corporation(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
8
8
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 20.41%

Current $198.71
Target $239.26

Company Financials

FY18Y/Y Change
Revenue
2.5B
↑ 8.58%
Net Income
410.6M
↑ 21.74%
Net Profit Margin
16.53%
↑ 1.79%
FY19Y/Y Change
Revenue
2.5B
↑ 0.44%
Net Income
425.5M
↑ 3.64%
Net Profit Margin
17.06%
↑ 0.53%
FY20Y/Y Change
Revenue
2.4B
↓ 5.73%
Net Income
377.8M
↓ 11.21%
Net Profit Margin
16.07%
↓ 0.99%
FY21Y/Y Change
Revenue
2.8B
↑ 17.57%
Net Income
449.4M
↑ 18.95%
Net Profit Margin
16.25%
↑ 0.18%
FY22Y/Y Change
Revenue
3.2B
↑ 15.09%
Net Income
586.9M
↑ 30.6%
Net Profit Margin
18.44%
↑ 2.19%
FY23Y/Y Change
Revenue
3.3B
↑ 2.89%
Net Income
596.1M
↑ 1.57%
Net Profit Margin
18.21%
↓ 0.23%
Q4 FY22Q/Q Change
Revenue
810.7M
↓ 1.61%
Net Income
130.0M
↓ 27.25%
Net Profit Margin
16.04%
↓ 5.65%
Q1 FY23Q/Q Change
Revenue
845.4M
↑ 4.28%
Net Income
139.8M
↑ 7.54%
Net Profit Margin
16.54%
↑ 0.5%
Q2 FY23Q/Q Change
Revenue
846.2M
↑ 0.09%
Net Income
138.6M
↓ 0.86%
Net Profit Margin
16.38%
↓ 0.16%
Q3 FY23Q/Q Change
Revenue
793.4M
↓ 6.24%
Net Income
209.1M
↑ 50.87%
Net Profit Margin
26.35%
↑ 9.97%
Q4 FY23Q/Q Change
Revenue
788.9M
↓ 0.57%
Net Income
108.6M
↓ 48.06%
Net Profit Margin
13.77%
↓ 12.58%
Q1 FY24Q/Q Change
Revenue
800.5M
↑ 1.47%
Net Income
121.4M
↑ 11.79%
Net Profit Margin
15.17%
↑ 1.4%
FY18Y/Y Change
Total Assets
3.5B
↑ 2.09%
Total Liabilities
1.5B
↓ 2.34%
FY19Y/Y Change
Total Assets
3.8B
↑ 9.89%
Total Liabilities
1.6B
↑ 4.94%
FY20Y/Y Change
Total Assets
4.4B
↑ 15.74%
Total Liabilities
1.9B
↑ 20.85%
FY21Y/Y Change
Total Assets
4.9B
↑ 11.39%
Total Liabilities
2.1B
↑ 12.81%
FY22Y/Y Change
Total Assets
5.5B
↑ 12.09%
Total Liabilities
2.5B
↑ 16.94%
FY23Y/Y Change
Total Assets
5.9B
↑ 6.41%
Total Liabilities
2.3B
↓ 6.0%
Q4 FY22Q/Q Change
Total Assets
5.5B
↑ 12.66%
Total Liabilities
2.5B
↑ 18.29%
Q1 FY23Q/Q Change
Total Assets
5.7B
↑ 2.65%
Total Liabilities
2.4B
↓ 1.77%
Q2 FY23Q/Q Change
Total Assets
5.7B
↑ 1.09%
Total Liabilities
2.4B
↑ 0.51%
Q3 FY23Q/Q Change
Total Assets
5.7B
↓ 0.88%
Total Liabilities
2.3B
↓ 6.5%
Q4 FY23Q/Q Change
Total Assets
5.9B
↑ 3.45%
Total Liabilities
2.3B
↑ 1.82%
Q1 FY24Q/Q Change
Total Assets
5.9B
↑ 0.41%
Total Liabilities
2.3B
↓ 2.28%
FY18Y/Y Change
Operating Cash Flow
479.3M
↑ 10.77%
Investing Cash Flow
-81.4M
↑ 48.74%
Financing Cash Flow
-290.0M
↑ 4.54%
FY19Y/Y Change
Operating Cash Flow
528.1M
↑ 10.16%
Investing Cash Flow
-137.0M
↑ 68.26%
Financing Cash Flow
-227.6M
↓ 21.53%
FY20Y/Y Change
Operating Cash Flow
569.3M
↑ 7.8%
Investing Cash Flow
-172.6M
↑ 25.95%
Financing Cash Flow
-42.6M
↓ 81.28%
FY21Y/Y Change
Operating Cash Flow
565.3M
↓ 0.7%
Investing Cash Flow
-698.1M
↑ 304.52%
Financing Cash Flow
-9.5M
↓ 77.7%
FY22Y/Y Change
Operating Cash Flow
557.4M
↓ 1.4%
Investing Cash Flow
-917.2M
↑ 31.39%
Financing Cash Flow
-38.3M
↑ 303.16%
Q4 FY22Q/Q Change
Operating Cash Flow
167.3M
↓ 15.55%
Investing Cash Flow
-917.2M
↑ 308.73%
Financing Cash Flow
236.3M
↓ 404.9%
Q1 FY23Q/Q Change
Operating Cash Flow
147.9M
↓ 11.6%
Investing Cash Flow
-29.2M
↓ 96.82%
Financing Cash Flow
-45.2M
↓ 119.13%
Q2 FY23Q/Q Change
Operating Cash Flow
141.2M
↓ 4.53%
Investing Cash Flow
-147.4M
↑ 404.79%
Financing Cash Flow
-46.8M
↑ 3.54%
Q3 FY23Q/Q Change
Operating Cash Flow
226.6M
↑ 60.48%
Investing Cash Flow
-90.0M
↓ 38.94%
Financing Cash Flow
-194.7M
↑ 316.03%

Technicals Summary

Sell

Neutral

Buy

Idex Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Idex Corporation
Idex Corporation
-0.29%
-0.87%
-5.1%
-9.83%
22.35%
Emerson Electric Co.
Emerson Electric Co.
7.59%
24.61%
27.52%
19.61%
74.87%
Illinois Tool Works Inc.
Illinois Tool Works Inc.
0.19%
-6.01%
-4.44%
7.07%
53.15%
Parker-hannifin Corporation
Parker-hannifin Corporation
8.11%
18.67%
38.65%
78.4%
209.49%
Otis
Otis
1.56%
11.78%
12.78%
10.46%
117.41%
Eaton Corporation Plc
Eaton Corporation Plc
-0.04%
33.27%
55.26%
106.33%
289.15%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Idex Corporation
Idex Corporation
26.97
26.97
2.31
8.29
0.17
0.08
0.01
47.68
Emerson Electric Co.
Emerson Electric Co.
35.07
35.07
2.3
5.47
0.09
0.05
0.02
36.54
Illinois Tool Works Inc.
Illinois Tool Works Inc.
24.22
24.22
2.67
10.35
1.0
0.17
0.02
10.12
Parker-hannifin Corporation
Parker-hannifin Corporation
25.97
25.97
2.26
24.84
0.26
0.09
0.01
90.17
Otis
Otis
28.75
28.75
2.69
3.87
0.0
0.15
0.02
-12.43
Eaton Corporation Plc
Eaton Corporation Plc
37.86
37.86
3.26
10.53
0.19
0.07
0.01
48.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Idex Corporation
Idex Corporation
Buy
$15.5B
22.35%
26.97
17.89%
Emerson Electric Co.
Emerson Electric Co.
Buy
$67.4B
74.87%
35.07
64.97%
Illinois Tool Works Inc.
Illinois Tool Works Inc.
Hold
$73.2B
53.15%
24.22
19.07%
Parker-hannifin Corporation
Parker-hannifin Corporation
Buy
$71.0B
209.49%
25.97
13.95%
Otis
Otis
Buy
$40.2B
117.41%
28.75
9.99%
Eaton Corporation Plc
Eaton Corporation Plc
Buy
$128.1B
289.15%
37.86
14.38%

Insights on Idex Corporation

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 788.9M → 800.5M (in $), with an average increase of 1.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 108.6M → 121.4M (in $), with an average increase of 10.5% per quarter

  • Vs ETN

    In the last 1 year, Eaton Corporation Plc has given 55.3% return, outperforming this stock by 60.4%

  • Vs ETN

    In the last 3 years, Eaton Corporation Plc has given 105.4% return, outperforming this stock by 115.9%

Institutional Holdings

  • Vanguard Group Inc

    12.16%
  • T. Rowe Price Associates, Inc.

    10.52%
  • BlackRock Inc

    8.04%
  • State Street Corporation

    3.94%
  • Morgan Stanley - Brokerage Accounts

    3.03%
  • Impax Asset Management Group PLC

    2.59%

Corporate Announcements

  • Idex Corporation Dividends March,2024

    In the quarter ending March,2024. Idex Corporation has declared dividend of $0.64

    Read More

Company Information

idex (nyse: iex) is a company that has undoubtedly touched your life in some way. in fact, idex businesses make thousands of products that are mission-critical components in everyday activities. chances are the car you’re driving has a band-it® clamp holding your side airbag safely in place. if you were ever in a car accident, a hurst jaws of life® rescue tool may have saved your life. if you or a family member is battling cancer, your doctor may have tested your dna in a quest to find the best targeted medicine for you. it’s likely your dna test was run on equipment that contains components made by our growing idex health & science team.

Organization
Idex Corporation
Employees
8800
CEO
Mr. Eric D. Ashleman
Industry
Producer Manufacturing

FAQs